Evidence map›Paper›PMID 35416103›Full record

ArticleToxicologic pathology2022

Developing a Solution for Nasal and Olfactory Transport of Nanomaterials.

Ryan C O'Connell, Tiana M Dodd, Sidney M Clingerman, Kara L Fluharty, Jayme Coyle, Todd A Stueckle, Dale W Porter, Lauren Bowers, Aleksandr B Stefaniak, Alycia K Knepp and 6 more

Open access · greenAbstract read
In one paragraph

Article in Toxicologic pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Ryan C O'ConnellCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Tiana M DoddCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Sidney M ClingermanCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Kara L FluhartyCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Jayme CoyleCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Todd A StueckleCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Dale W PorterCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Lauren BowersCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Aleksandr B StefaniakCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Alycia K KneppCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Raymond DerkCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Michael WolfarthCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Robert R MercerCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Theresa E BootsCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Krishnan SriramCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.
Ann F HubbsCenters for Disease Control and Prevention, Morgantown, West Virginia, USA.ORCID 0000-0001-8631-5123
Centers for Disease Control and Prevention · USWest Virginia University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

With advances in nanotechnology, engineered nanomaterial applications are a rapidly growing sector of the economy. Some nanomaterials can reach the brain through nose-to-brain transport. This transport creates concern for potential neurotoxicity of insoluble nanomaterials and a need for toxicity screening tests that detect nose-to-brain transport. Such tests can involve intranasal instillation of aqueous suspensions of nanomaterials in dispersion media that limit particle agglomeration. Unfortunately, protein and some elements in existing dispersion media are suboptimal for potential nose-to-brain transport of nanomaterials because olfactory transport has size- and ion-composition requirements. Therefore, we designed a protein-free dispersion media containing phospholipids and amino acids in an isotonic balanced electrolyte solution, a solution for nasal and olfactory transport (SNOT). SNOT disperses hexagonal boron nitride nanomaterials with a peak particle diameter below 100 nm. In addition, multiwalled carbon nanotubes (MWCNTs) in an established dispersion medium, when diluted with SNOT, maintain dispersion with reduced albumin concentration. Using stereomicroscopy and microscopic examination of plastic sections, dextran dyes dispersed in SNOT are demonstrated in the neuroepithelium of the nose and olfactory bulb of B6;129P2-

Indexed as

NanostructuresNanotubes, CarbonAdministration, IntranasalAnimalsBrainMiceOlfactory BulbToxicity TestsNanotubes, Carbondispersion mediananomaterialsnanotoxicologyneurotoxicologynose-to-brain transportolfactory transporttransport mechanisms

Identifiers

PMID35416103
PMCPMC9872725
OpenAlexW4223424242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.